Nerve Gas Agent Pyridostigmine Is First Approval Under Animal Efficacy Rule
Executive Summary
FDA's approval of pyridostigmine bromide as a pretreatment against Soman nerve gas is the first under the agency's animal efficacy rule
You may also be interested in...
Levaquin Approval For Plague Carries Just One Postmarketing Requirement
Study requirement for J&J’s antibiotic is less onerous than the studies that were imposed for the two other products approved under the Animal Rule.
Animal Rule Studies Should Be As Well-Designed As Human Clinical Trials, Panel Says
FDA's Anti-Infective Drugs Advisory Committee unanimously said ciprofloxacin and Ortho-McNeil-Janssen Pharmaceuticals Inc.’s Levaquin (levofloxacin) had proven their efficacy for pneumonic plague in studies in African Green Monkeys, but the panel may be less willing to overlook study design flaws in less life-threatening conditions.
FDA Animal Efficacy Rule Drops Superiority Requirement For New Agents
FDA's final rule allowing drug approvals based on animal efficacy studies will permit more than one drug to be approved for an indication without a clear demonstration of superiority over existing products